Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
16.04.23 | Affimed N.V.: Affimed Presents Final Data Demonstrating Safety and Efficacy of AFM13 Phase 2 REDIRECT Study in Patients with Heavily Pretreated Relapsed or Refractory Peripheral T Cell Lymphoma at the American Association for Cancer Research Annual Meetin | 346 | GlobeNewswire (Europe) | AFM13 demonstrated robust activity on the primary end point with an objective response rate (ORR) of 32.4% and 10.2% complete response rate (CR) in Intent to Treat (ITT) populationPatients with Angioimmunoblastic... ► Artikel lesen | |
16.04.23 | Merck & Co., Inc. Strengthens Immunology Pipeline with Acquisition of Prometheus Biosciences, Inc. | 370 | GlobeNewswire (Europe) | PRA023 is a novel, late-stage candidate for ulcerative colitis and Crohn's disease and other autoimmune conditions Prometheus Biosciences' comprehensive data set enables target discovery and precision... ► Artikel lesen | |
16.04.23 | Norsk Hydro: Strike at Hydro Karmøy and Hydro Årdal | 572 | GlobeNewswire (Europe) | Following the breach in mediation between The Confederation of Norwegian Enterprise (NHO), the Confederation of the Vocational Unions (YS) and the Norwegian Labor Union (LO), employees organized in... ► Artikel lesen | |
16.04.23 | F. Hoffmann-La Roche Ltd: Roche's Tecentriq plus Avastin reduced the risk of cancer returning in people with certain types of adjuvant liver cancer in a Phase III study | 676 | GlobeNewswire (Europe) | In the first-ever positive Phase III trial in the adjuvant hepatocellular carcinoma (HCC) setting, Tecentriq plus Avastin reduced the risk of disease recurrence by 28%1Up to 80% of people with this... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
EVOTEC | 5.325 |
NVIDIA | 3.549 |
TUI | 2.941 |
GAMESTOP | 2.776 |
BAYER | 2.290 |
NEL | 2.101 |
RHEINMETALL | 1.808 |
BYD | 1.672 |
DEUTSCHE LUFTHANSA | 1.414 |
TESLA | 1.192 |
VOLKSWAGEN | 1.057 |
CARL ZEISS MEDITEC | 1.002 |
SUPER MICRO COMPUTER | 886 |
APPLE | 835 |
BASF | 829 |
CAVENDISH HYDROGEN | 820 |
AIXTRON SE | 812 |
THYSSENKRUPP | 789 |
COMMERZBANK | 787 |
DEFI TECHNOLOGIES | 771 |
PORSCHE SE | 692 |
DEUTSCHE BANK | 675 |
RENK GROUP | 652 |
MERCEDES-BENZ | 642 |
BIONTECH | 628 |